Amrie Grammer: Pioneering Precision Medicine for Autoimmune and Inflammatory Diseases

Amrie Grammer, Founder and CSO of AMPEL Biosolutions, is revolutionizing autoimmune and inflammatory disease treatment by integrating RNA analytics and AI. Her work enables personalized therapies for conditions like lupus, psoriasis, and rheumatoid arthritis, paving the way for more effective healthcare. 

Grammer emphasizes the role of chronic inflammation in aging and disease. AMPEL’s blood and biopsy tests provide actionable insights, empowering individuals to adopt lifestyle changes or seek anti-inflammatory treatments. “Inflammation is the barrier to a long, healthy life,” she states, highlighting AMPEL's focus on early intervention and personalized care.

Learn more